90
Participants
Start Date
January 11, 2021
Primary Completion Date
May 27, 2024
Study Completion Date
December 5, 2024
High dose allogeneic mesenchymal stromal cells
Allogeneic mesenchymal stromal cells derived from adipose tissue administered intramuscularly
Low dose allogeneic mesenchymal stromal cells
Allogeneic mesenchymal stromal cells derived from adipose tissue administered intramuscularly
Placebos
0,9% physiological saline
Hospital General de Alicante, Alicante
Hospital Gregorio Marañon, Madrid
Hospital Universitario Fundacion Jimenez Diaz, Madrid
La Paz University Hospital, Madrid
Hospital Clinico Universitario Virgen de la Arrixaca, Murcia
Clinica Universidad de Navarra, Pamplona
Hospital Universitario de Salamanca, Salamanca
Hospital Victoria Eugenia Cruz Roja Española, Seville
Hospital Universitario La Fe, Valencia
Hospital de Valladolid, Valladolid
Clinica Universidad de Navarra, Universidad de Navarra
OTHER
Hospital Universitario La Paz
OTHER
Gregorio Marañón Hospital
OTHER
Hospital Clínico Universitario de Valladolid
OTHER
Hospital Universitario Virgen de la Arrixaca
OTHER
University of Salamanca
OTHER
Hospital General Universitario de Alicante
OTHER
Hospital Universitario La Fe
OTHER
Hospital Victoria Eugenia Cruz Roja Española
UNKNOWN
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
OTHER